Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.

MLA

Epstein, Robert S., et al. “Real-World Burden of Chemotherapy-Induced Myelosuppression in Patients with Small Cell Lung Cancer: A Retrospective Analysis of Electronic Medical Data from Community Cancer Care Providers.” Journal of Medical Economics, vol. 25, no. 1, Jan. 2022, pp. 108–18. EBSCOhost, https://doi.org/10.1080/13696998.2021.2020570.

APA

Epstein, R. S., Weerasinghe, R. K., Parrish, A. S., Krenitsky, J., Sanborn, R. E., & Salimi, T. (2022). Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers. Journal of Medical Economics, 25(1), 108–118. https://doi.org/10.1080/13696998.2021.2020570

Chicago

Epstein, Robert S, Roshanthi K Weerasinghe, Amy S Parrish, JoAnn Krenitsky, Rachel E Sanborn, and Tehseen Salimi. 2022. “Real-World Burden of Chemotherapy-Induced Myelosuppression in Patients with Small Cell Lung Cancer: A Retrospective Analysis of Electronic Medical Data from Community Cancer Care Providers.” Journal of Medical Economics 25 (1): 108–18. doi:10.1080/13696998.2021.2020570.